WRITING THAT
RESPECTS YOUR TIME.
Comparisons, explainers, and running research digests. No 2,000-word SEO fluff. If a claim doesn't have a citation, it doesn't go in.
BPC-157 vs TB-500: Comparing the Two Most Popular Healing Peptides
A comprehensive comparison of BPC-157 and TB-500 — their mechanisms, research findings, and how researchers use them together.
Retatrutide Phase 3: The 28.7% Number, In Context
Lilly's triple agonist just posted the highest weight-loss result ever recorded in a Phase 3 obesity trial. Here's what TRIUMPH actually showed — and what it didn't.
BPC-157: The Complete Guide to the Healing Peptide
Everything you need to know about BPC-157 — mechanisms, research, dosing, and what the science actually says. Updated for 2026.
How GLP-1 Agonists Actually Work (Simple Explanation)
A clear, jargon-free explanation of how medications like Ozempic, Wegovy, and Mounjaro cause weight loss.
How to Inject Peptides: A Beginner's Guide
Step-by-step instructions for subcutaneous peptide injections. Safety tips, technique, and common mistakes to avoid.
The Ipamorelin + CJC-1295 Stack Explained
Why these two peptides are better together. Understanding GHRP/GHRH synergy for optimal GH release.
Are Peptides Safe? What the Research Says
An honest look at peptide safety — FDA-approved vs research peptides, risks, and how to minimize them.
Beginner's Guide to GLP-1 Peptides: Semaglutide vs Tirzepatide
Everything beginners need to know about GLP-1 peptides — how they work, key differences between semaglutide and tirzepatide, and what researchers report.
How to Read a Certificate of Analysis (COA)
Learn to evaluate peptide quality by understanding COAs — what to look for, red flags to avoid, and how to verify authenticity.
Peptide Storage Mistakes That Are Wasting Your Money
The most common peptide storage errors that destroy potency and waste your investment. Learn what to avoid and how to store peptides properly.
Why Peptide Purity Matters: Understanding the 98%+ Standard
What peptide purity actually means, how it's tested, and why quality costs more but saves money long-term.
How to Reconstitute Peptides: Step-by-Step Guide (2026)
Complete guide to peptide reconstitution — equipment needed, step-by-step instructions, dosing calculations, storage tips, and common mistakes to avoid.
Semaglutide vs Tirzepatide: Complete Comparison (2026)
In-depth comparison of semaglutide and tirzepatide — mechanisms, weight loss data, side effects, costs, and which GLP-1 peptide is right for different research goals.
Best Peptides for Women: Complete Guide (2026)
Comprehensive guide to peptides for women — hormonal considerations, top peptides by goal, safety guidelines, and what female researchers should know.
Orforglipron: The First Oral Non-Peptide GLP-1, Coming 2026
Lilly's once-daily oral GLP-1 is under FDA review with a mid-2026 decision expected. It's not a peptide — and that's exactly the point.
CagriSema: Novo's Answer to the Triple-Agonist Era
REDEFINE 1 showed 22.7% weight loss with the semaglutide + cagrilintide combo. Novo is filing for regulatory approval in 2026. Here is the case for and against it.
Tesamorelin Is Making a Comeback in 2026
FDA-approved since 2010, this GHRH analog has quietly become the most interesting growth-hormone peptide for off-label use. Here is why researchers are paying attention again.
FDA Peptide Reclassification 2026: What Actually Changed
Since 2023, the FDA has progressively tightened rules around compounding peptides. Here is what is legal, what is not, and what changed in 2025–2026.
Preserving Muscle On GLP-1s: Why It Matters, How To Do It
25–40% of weight lost on GLP-1s can come from muscle. Here's the protein + resistance training protocol that keeps you lean instead of skinny-fat.
Follistatin-344 And The Myostatin Story
The protein that caps how much muscle you can build. The peptide that neutralizes it. The reality check on what that actually means for humans.
SLU-PP-332: The Exercise Mimetic That Works In Mice
A small molecule that makes sedentary mice run 50% farther. No human data yet. But the mechanism is real — and different from everything else.
SS-31 (Elamipretide): Mitochondrial Peptides Grow Up
Thirty years after the first cardiolipin-binding compounds were characterized, SS-31 is in Phase 3 for Barth syndrome. Here's why mitochondrial peptides are finally getting serious.
5-Amino-1MQ And NNMT Inhibition: Lean Fat Loss Explained
The enzyme that steals NAD+ from your fat cells. The compound that blocks it. And the surprisingly specific way this might help with sarcopenic obesity.
Survodutide And The Liver: A Dual Agonist's Specific Niche
Boehringer Ingelheim is betting that GLP-1/glucagon dual agonism is the answer for MASH — and the Phase 3 data is coming in 2026.
KPV: The Anti-Inflammatory Tripeptide Nobody Talks About
A three-amino-acid fragment of α-MSH with potent anti-inflammatory effects, oral bioavailability, and a remarkably clean safety record. Why is nobody talking about this?
Compounded Semaglutide In 2026: What Changed, What's Next
The FDA removed semaglutide from shortage in early 2025. Compounding pharmacies scrambled. Legal battles followed. Here is what actually happened and what to do.
MOTS-c: The Mitochondrial Peptide That's Finally Getting Traction
Encoded in mitochondrial DNA, it's a metabolic regulator that mimics exercise adaptations. Human trials are starting. Here's what we actually know.